Sponsor Pipeline

Zhejiang Teruisi Pharmaceutical Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06886139 A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL. CD20-positive Diffuse Large B-Cell Lymphoma Not Yet Recruiting
Phase 1/2
NCT07035379 A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and… Diffuse Large B-Cell Lymphoma (DLBCL) Not Yet Recruiting
Phase 1
NCT05395533 A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL. CD20-positive B-cell Non-Hodgkin Lymphoma Active, Not Recruiting
Disease Areas
DLBCL (2) Non-Hodgkin Lymphoma (1)
Get alerts when Zhejiang Teruisi Pharmaceutical Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free